Bayer Group
Consolidated Statements of Cash Flows

 

 

Q1 2016

 

Q1 2017

 

 

€ million

 

€ million

2016 figures restated

Income from continuing operations after income taxes

 

1,531

 

2,172

Income taxes

 

474

 

595

Financial result

 

315

 

349

Income taxes paid

 

(478)

 

(522)

Depreciation, amortization and impairments

 

1,039

 

730

Change in pension provisions

 

(99)

 

(54)

(Gains) losses on retirements of noncurrent assets

 

(2)

 

(57)

Decrease (increase) in inventories

 

(119)

 

(257)

Decrease (increase) in trade accounts receivable

 

(1,668)

 

(1,970)

(Decrease) increase in trade accounts payable

 

(893)

 

(694)

Changes in other working capital, other noncash items

 

452

 

534

Net cash provided by (used in) operating activities from continuing operations

 

552

 

826

Net cash provided by (used in) operating activities from discontinued operations

 

770

 

15

Net cash provided by (used in) operating activities (total)

 

1,322

 

841

Cash outflows for additions to property, plant, equipment and intangible assets

 

(363)

 

(415)

Cash inflows from the sale of property, plant, equipment and other assets

 

21

 

54

Cash inflows from divestitures

 

 

Cash inflows from (outflows for) noncurrent financial assets

 

(252)

 

(54)

Cash outflows for acquisitions less acquired cash

 

2

 

(158)

Interest and dividends received

 

22

 

20

Cash inflows from (outflows for) current financial assets

 

108

 

(583)

Net cash provided by (used in) investing activities (total)

 

(462)

 

(1,136)

Proceeds from shares of Covestro AG

 

 

1,460

Dividend payments

 

 

Issuances of debt

 

4,322

 

292

Retirements of debt

 

(3,413)

 

(1,036)

Interest paid including interest-rate swaps

 

(101)

 

(114)

Interest received from interest-rate swaps

 

15

 

9

Cash outflows for the purchase of additional interests in subsidiaries

 

 

Net cash provided by (used in) financing activities (total)

 

823

 

611

Change in cash and cash equivalents due to business activities (total)

 

1,683

 

316

Cash and cash equivalents at beginning of period

 

1,859

 

1,899

Change in cash and cash equivalents due to changes in scope of consolidation

 

(1)

 

Change in cash and cash equivalents due to exchange rate movements

 

11

 

9

Cash and cash equivalents at end of period

 

3,552

 

2,224